Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.


All category news

  • Clemson University students, visitors warned after confirmed mumps case

    December 4, 2018 7:32 PM 167

    The timeframe includes when the Tigers played host to the South Carolina Gamecocks on Nov. 24 in a 56-35 home victory for Clemson. (iStock) Health officials are warning anyone who visited or was around Clemson University near the end of November to be on alert after a case of mumps was connected to campus. According to the South Carolina Department of Health

  • Beef recall expands to 12 million pounds over salmonella fears

    December 4, 2018 4:31 PM 101

    The U.S. Department of Agriculture says a unit of Brazil's JBS is now recalling a total of more than 12 million pounds of raw beef that was shipped around the country. (iStock) More U.S. beef is being recalled because it may be contaminated with salmonella. The U.S. Department of Agriculture says a unit of Brazil's JBS is now recalling a total of more than 12 million

  • Montana 6-year-old is state's first flu death of season, family says

    December 4, 2018 2:53 PM 152

    While health officials declined to reveal additional details, family members have identified the victim as 6-year-old Allison Eaglespeaker, a kindergartener who died of influenza B and pneumonia on Saturday. (GoFundMe) The Montana Department of Public Health has confirmed the state’s first flu death of the season, revealing that the fatality is a child

  • Roche says Hemlibra effective in pivotal study

    December 3, 2018 7:41 PM 109

    ZURICH (Reuters) - Roche’s Hemlibra provided sustained bleed control in the largest pivotal study to date of children with a form of haemophilia, the Swiss drugmaker said on Monday. Nearly 77 percent of children receiving Hemlibra once weekly experienced no treated bleeds, while Hemlibra once weekly reduced treated bleeds by 99 percent compared to prior

  • Surgeons remove massive cancerous tumor from man's jaw

    December 3, 2018 2:23 PM 121

    Majeed N, 45, from India, underwent a painstaking 12-hour facelift surgery to have the cancerous lump cut out. (SWNS) A dad-of-four who hid his face from the world for 10 years has embarked on a new life after having an enormous 5.3kg (approx. 11.6 pounds) tumor removed from his face. Majeed N, 45, from India, underwent a painstaking 12-hour facelift

  • Dutch firm argenx, J&J affiliate to collaborate on cancer therapy

    December 3, 2018 9:12 AM 133

    (Reuters) - Netherlands-based biopharmaceutical company argenx SE said it signed a deal with Cilag GmbH International, an affiliate of Johnson & Johnson’s Janssen Pharmaceutical Companies unit, to develop its Cusatuzumab drug in certain types of cancer. The deal, which is potentially worth up to $1.6 billion, represents a global collaboration and licensing

  • Novartis SMA treatment could get FDA approval in May

    December 3, 2018 6:41 AM 114

    ZURICH (Reuters) - Novartis’s gene therapy for spinal muscular atrophy (SMA) could be approved in May 2019 after the U.S. Food and Drug Administration agreed to an accelerated review of the Swiss drugmaker’s treatment. Novartis SMA treatment, now called Zolgensma, said on Monday it won FDA priority review after submitting clinical trial results for 15 patients

  • 5 middle-school students hospitalized after eating THC-laced candies during gym

    November 30, 2018 2:45 PM 127

    The Polk County Sheriff’s Office said the candies were brought to Mulberry Middle School by a 12-year-old 7th-grader. (Polk County Sheriff's Office; Google) Five students at Mulberry Middle School in Mulberry, Fla., were hospitalized on Thursday – and at least one other was retrieved from class by parents – after complaining of nausea, stomach aches

  • 'Echo chamber' surrounds parental decisions about childhood flu vaccine

    November 29, 2018 8:37 PM 141

    (Reuters Health) - Although the annual flu vaccine is recommended for all children older than 6 months, about a third of parents say their child won’t receive one this year, according to a new U.S. poll. Parents seem to make decisions in an “echo chamber” of information that reinforces their beliefs about flu vaccines, the co-directors of the National

  • FDA approves first biosimilar to Roche cancer drug Rituxan

    November 29, 2018 12:49 AM 126

    (Reuters) - Celltrion Inc’s Truxima on Wednesday became the first biosimilar to Roche Holding AG’s $7-billion-per-year cancer drug Rituxan to be approved in the United States to treat non-Hodgkin’s lymphoma. The approval by the U.S. Food and Drug Administration is part of the agency’s plan to encourage development of cheaper biosimilars amid rising prices